Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Japan Tobacco discontinues JTE-522 development

Sep. 18, 2003

Limited activity described for exatecan mesilate as first-line monotherapy in NSCLC

Sep. 18, 2003

Odyssey and Dharmacon investigate effects of siRNA-induced gene silencing

Sep. 18, 2003

Panacea expands research agreement with MIT

Sep. 17, 2003

New trial approved to evaluate GTI-2040 in combination with docetaxel for NSCLC

Sep. 17, 2003

Efficacy of drug for dry mouth in preventing lung cancer claimed in recent patent

Sep. 17, 2003

DOS-47 demonstrates preclinical antitumor activity

Sep. 17, 2003

Market launch announced for Aloxi

Sep. 16, 2003

Advisory committee does not recommend approval of Metvix for basal cell carcinoma

Sep. 16, 2003

Bioenvision obtains clofarabine option in Japan and South East Asia

Sep. 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...